Quick Answer
Cannabis Bioscience International Holdings, Inc. reported Operating Income of -$421.4 thousand for fiscal year 2025.
Cannabis Bioscience International Holdings, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$421.4K | +13.3% |
| 2024 | -$486.1K | +50.6% |
| 2023 | -$983.4K | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| November 30, 2025 | -$95.9K | -60.8% | -28.2% |
| August 31, 2025 | -$74.8K | +23.4% | -25.4% |
| November 30, 2024 | -$59.6K | +36.9% | +38.9% |
| August 31, 2024 | -$97.6K | +44.8% | +39.0% |
| February 29, 2024 | -$160.0K | +43.8% | -69.3% |
| November 30, 2023 | -$94.5K | +48.5% | +46.5% |
| August 31, 2023 | -$176.8K | — | +37.9% |
| February 28, 2023 | -$284.9K | — | -55.1% |
- Cannabis Bioscience International Holdings, Inc. showed an increase of +13.3% in Operating Income compared to the prior fiscal year.
- Over the 2023–2025 period, Cannabis Bioscience International Holdings, Inc.’s operating income has grown by 57.2% (from -$983.4 thousand to -$421.4 thousand).
- The most recent figure is from Cannabis Bioscience International Holdings, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on September 22, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: